
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6125607
[patent_doc_number] => 20110086074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'COMBINATIONS OF NIACIN AND AN OXICAM'
[patent_app_type] => utility
[patent_app_number] => 12/995711
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13951
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995711 | COMBINATIONS OF NIACIN AND AN OXICAM | Jun 1, 2009 | Abandoned |
Array
(
[id] => 9085865
[patent_doc_number] => 08557291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Abuse-deterrent pharmaceutical compositions of opioids and other drugs'
[patent_app_type] => utility
[patent_app_number] => 12/473073
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12473073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473073 | Abuse-deterrent pharmaceutical compositions of opioids and other drugs | May 26, 2009 | Issued |
Array
(
[id] => 5490063
[patent_doc_number] => 20090291134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/470219
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18566
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291134.pdf
[firstpage_image] =>[orig_patent_app_number] => 12470219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470219 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES | May 20, 2009 | Abandoned |
Array
(
[id] => 6375599
[patent_doc_number] => 20100076033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Methods For Treating Hyperlipidemia with Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics'
[patent_app_type] => utility
[patent_app_number] => 12/470422
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13356
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12470422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470422 | Methods For Treating Hyperlipidemia with Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics | May 20, 2009 | Abandoned |
Array
(
[id] => 5551919
[patent_doc_number] => 20090285905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'SYSTEMS AND PROCESSES FOR SPRAY DRYING HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/469634
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9086
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469634 | Systems and processes for spray drying hydrophobic and hydrophilic components | May 19, 2009 | Issued |
Array
(
[id] => 5538811
[patent_doc_number] => 20090220616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'MOISTURIZING AND LUBRICATING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/437136
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10453
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12437136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/437136 | MOISTURIZING AND LUBRICATING COMPOSITIONS | May 6, 2009 | Abandoned |
Array
(
[id] => 6007136
[patent_doc_number] => 20110059167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/991521
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10486
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991521
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991521 | ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS | May 4, 2009 | Abandoned |
Array
(
[id] => 5380344
[patent_doc_number] => 20090192183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Oxymorphone Controlled Release Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/426112
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12846
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426112 | Oxymorphone Controlled Release Formulations | Apr 16, 2009 | Abandoned |
Array
(
[id] => 5495453
[patent_doc_number] => 20090263481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'LEVETIRACETAM FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/425051
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5060
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263481.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425051
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425051 | LEVETIRACETAM FORMULATIONS | Apr 15, 2009 | Abandoned |
Array
(
[id] => 5480828
[patent_doc_number] => 20090203785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHOD AND PROCESS FOR PRODUCING YOUTHFUL-APPEARING, SMALL-PORED, AND SMOOTH SKIN'
[patent_app_type] => utility
[patent_app_number] => 12/421792
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3809
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421792
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421792 | METHOD AND PROCESS FOR PRODUCING YOUTHFUL-APPEARING, SMALL-PORED, AND SMOOTH SKIN | Apr 9, 2009 | Abandoned |
Array
(
[id] => 5538785
[patent_doc_number] => 20090220590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Triple drug combinations for psychiatric patients'
[patent_app_type] => utility
[patent_app_number] => 12/384451
[patent_app_country] => US
[patent_app_date] => 2009-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 824
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384451
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384451 | Triple drug combinations for psychiatric patients | Apr 5, 2009 | Abandoned |
Array
(
[id] => 5385282
[patent_doc_number] => 20090226527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Particulate-stabilized injectable pharmacutical compositions of posaconazole'
[patent_app_type] => utility
[patent_app_number] => 12/380790
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21194
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226527.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380790 | Particulate-stabilized injectable pharmacutical compositions of posaconazole | Mar 2, 2009 | Abandoned |
Array
(
[id] => 5391259
[patent_doc_number] => 20090208572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'ORAL CONTROLLED RELEASE TABLET'
[patent_app_type] => utility
[patent_app_number] => 12/372161
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11737
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12372161
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/372161 | ORAL CONTROLLED RELEASE TABLET | Feb 16, 2009 | Abandoned |
Array
(
[id] => 5302942
[patent_doc_number] => 20090297594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID'
[patent_app_type] => utility
[patent_app_number] => 12/368076
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10619
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297594.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368076 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID | Feb 8, 2009 | Issued |
Array
(
[id] => 6024427
[patent_doc_number] => 20110052753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR INFLUENCING RECOVERY FROM STRENUOUS PHYSICAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/735651
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14728
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 62
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052753.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735651 | Compositions and methods for influencing recovery from strenuous physical activity | Feb 4, 2009 | Issued |
Array
(
[id] => 6389188
[patent_doc_number] => 20100317746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'IMPROVED ISOMALT-CONTAINING TABLETS AND METHODS FOR THE PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/867860
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7424
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317746.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867860 | Isomalt-containing tablets and methods for the production thereof | Feb 3, 2009 | Issued |
Array
(
[id] => 5526858
[patent_doc_number] => 20090196935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets'
[patent_app_type] => utility
[patent_app_number] => 12/364241
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6824
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364241 | Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets | Feb 1, 2009 | Abandoned |
Array
(
[id] => 5342787
[patent_doc_number] => 20090181437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Method for producing a conjugated linoleic acid glyceride'
[patent_app_type] => utility
[patent_app_number] => 12/321671
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8272
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181437.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321671 | Method for producing a conjugated linoleic acid glyceride | Jan 22, 2009 | Abandoned |
Array
(
[id] => 6552643
[patent_doc_number] => 20100288795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'SILICON DIOXIDE DISPERSION'
[patent_app_type] => utility
[patent_app_number] => 12/863096
[patent_app_country] => US
[patent_app_date] => 2008-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20100288795.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863096
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863096 | SILICON DIOXIDE DISPERSION | Dec 29, 2008 | Abandoned |
Array
(
[id] => 5435032
[patent_doc_number] => 20090169618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Zolpidem pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/317834
[patent_app_country] => US
[patent_app_date] => 2008-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7472
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169618.pdf
[firstpage_image] =>[orig_patent_app_number] => 12317834
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317834 | Zolpidem pharmaceutical compositions | Dec 28, 2008 | Abandoned |